Isolation of human intrahepatic leukocytes for phenotypic and functional characterization by flow cytometry.
Cell isolation
Flow Cytometry/Mass Cytometry
Health Sciences
Immunology
Single Cell
Journal
STAR protocols
ISSN: 2666-1667
Titre abrégé: STAR Protoc
Pays: United States
ID NLM: 101769501
Informations de publication
Date de publication:
17 06 2022
17 06 2022
Historique:
entrez:
6
5
2022
pubmed:
7
5
2022
medline:
10
5
2022
Statut:
epublish
Résumé
With the growing appreciation of tissue-resident immunity, studying tissue-specific immune cells contributing to both homeostasis and disease is imperative. Here, we provide a protocol for the isolation of human intrahepatic leukocytes (IHL) maximizing viability, purity, and yield. Our protocol is scalable by tissue weight, allowing for reproducible and efficient IHL liberation suitable for functional characterization, cell isolation, and profiling by flow (or mass) cytometry. Furthermore, we provide a "guide" to determine an expected IHL yield per gram of tissue processed. For complete details on the use and execution of this protocol, please refer to Stegmann et al. (2016), Pallett et al. (2017), Easom et al. (2018), Swadling et al. (2020), Pallett et al. (2020), and Zakeri et al. (2022).
Identifiants
pubmed: 35516846
doi: 10.1016/j.xpro.2022.101356
pii: S2666-1667(22)00236-2
pmc: PMC9065431
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
101356Subventions
Organisme : Cancer Research UK
ID : 26813
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0801213
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 214191/Z/18/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101849/Z/13/A
Pays : United Kingdom
Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
The authors declare no competing interests.
Références
Lab Invest. 2005 Feb;85(2):285-96
pubmed: 15640833
Front Immunol. 2013 Mar 11;4:61
pubmed: 23482713
Int Immunopharmacol. 2020 Aug;85:106632
pubmed: 32470880
J Hepatol. 1998 Aug;29(2):300-5
pubmed: 9722212
J Exp Med. 2017 Jun 5;214(6):1567-1580
pubmed: 28526759
J Exp Med. 2020 Sep 7;217(9):
pubmed: 32602903
J Immunol Methods. 2000 Aug 28;242(1-2):21-31
pubmed: 10986386
Eur J Immunol. 2021 Dec;51(12):2708-3145
pubmed: 34910301
Nat Commun. 2022 Mar 16;13(1):1372
pubmed: 35296658
Cell Rep. 2020 Jan 21;30(3):687-698.e6
pubmed: 31968246
Sci Rep. 2016 May 23;6:26157
pubmed: 27210614
Front Immunol. 2018 May 09;9:1009
pubmed: 29867983